SEPRAFILM
Seprafilm is a mechanical bioresorbable adhesion barrier that is applied to adhesiogenic tissues before surgical closure. It is indicated for the reduction in the incidence, extent, and severity of postoperative adhesions in patients undergoing abdominal or pelvic laparotomy.
SEPRAFILM
Industry:
Health Care
Founded:
1996-01-01
Address:
Bridgewater, New Jersey, United States
Country:
United States
Website Url:
http://www.seprafilm.us
Status:
Closed
Technology used in webpage:
DigiCert SSL
Similar Organizations
Mineral Air
Mineral Air offers a range of cosmetics and skin care products.
More informations about "Seprafilm"
Seprafilm - Crunchbase Company Profile & Funding
2,602 Number of Organizations • $88.5B Total Funding Amount • 1,582 Number of Investors. Track . ... Seprafilm is located in Bridgewater, New Jersey, …See details»
Seprafilm Adhesion Barrier | Baxter …
SEPRAFILM Adhesion Barrier efficacy in abdominal surgery In a randomized, prospective, double-blinded, multicenter clinical study involving 183 patients [175 evaluable] with ulcerative …See details»
Baxter Completes Acquisition of Seprafilm Adhesion Barrier
Feb 18, 2020 PDF . DEERFIELD, Ill. - 2020-02-18 Baxter International Inc. (NYSE:BAX), a leading global medical products company, has completed its previously announced acquisition …See details»
Adhesion barrier - Wikipedia
Global Adhesion Barrier Market Size is expected to reach US $ 15Mn by 2025 during the forecast period 2020 to 2025.The first commercially available adhesion barrier was probably Cargile Membrane, a preserved peritoneal membrane of the Danish Ox. Marketed by Johnson & Johnson around 1904, it was still available in the early 1990s. In the United States, Interceed, Seprafilm and Adept are the three products approved by the U.S. Food and Drug Administration (FDA) for …See details»
What is Seprafilm Adhesion Barrier?
Seprafilm Adhesion Barrier can be cut and tailored to fit the size and shape of the surgical area. 1 Once in place, it adheres to the tissue and forms a barrier. 1 The application process is …See details»
Baxter to Expand Advanced Surgery Portfolio With …
Dec 2, 2019 Delivers on Baxter’s strategy to acquire products that are a strong fit with the company’s leading hemostat and sealant portfolio Plans to support the product through Baxter’s dedicated surgery salesforce Baxter International …See details»
Baxter closes $350M acquisition of Sanofi's Seprafilm …
Dec 2, 2019 Sanofi gained Seprafilm in its $20 billion-plus buyout of Genzyme in 2011. The product has faced scrutiny from the Department of Justice and medical device safety watchdogs alike. The DOJ in 2013 ordered Genzyme to pay …See details»
BAXTER COMPLETES ACQUISITION OF SEPRAFILM ADHESION …
Seprafilm has been more extensively evaluated than any other adhesion barrier and has been found to significantly reduce the incidence, extent, and severity of adhesions following ... more, …See details»
SEPRAFILM - Baxter specialty Site
SEPRAFILM Adhesion Barrier is an adhesion barrier that reduces the incidence, extent and severity of adhesions following abdominopelvic surgery 1,2. ... About Us Every day, millions of patients and caregivers rely on Baxter’s leading …See details»
Premarket Approval (PMA) - Food and Drug Administration
The device, with the modified labeling, will be marketed under the trade name seprafilm adhesion barrier, and is indicated for use in patients undergoing abdominal or pelvic laparotomy as an …See details»
Paradoxical outcome after use of hyaluronate barrier to prevent …
A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock ... and secondary female infertility. At operation, strategies to …See details»
SEPRAFILM ADHESION BARRIER 510(k) FDA Approval
Approval for revised labeling for seprafilm adhesion barrier to reflect the interim findings of the study approved under g980066, "a prospective, randomized, multicenter, controlled evaluation …See details»
Seprafilm - Baxter
Seprafilm® Adhesion Barrier DESCRIPTION Seprafilm® Adhesion Barrier (Seprafilm) is a sterile, bioresorb-able, translucent membrane composed of two chemically modified anionic …See details»
PROTECT YOUR PATIENT'S FUTURE - baxterprofessional.co.nz
Events was not affected when Seprafilm was placed elsewhere in the abdomen. • Seprafilm is not recommended for use in women undergoing surgery for ovarian, fallopian tube or peritoneal …See details»
Baxter Completes Acquisition of Seprafilm Adhesion Barrier
Feb 18, 2020 Our more than 85-year heritage gives us distinct perspective on the needs of patients and caregivers. We lead today by putting those insights to work to deliver new, better …See details»
Wiki Seprafilm - Is it seperately reportable? - AAPC
Apr 29, 2009 I have surgeons who are placing seprafilm during open abdominal & pelvic surgeries. The purpose is to prevent adhesions from attaching to your organs... Menu. …See details»
Seprafilm® adhesion barrier: (1) a review of preclinical, animal, …
Preclinical evaluation of the efficacy of Seprafilm in a rat cecal abrasion or side wall injury model demonstrated that Seprafilm significantly reduced the incidence of cecal adhesions (P < …See details»
Seprafilm ® adhesion barrier: (2) a review of the clinical literature ...
Apr 15, 2012 This study seeks to provide a review of the clinical data published as of July 2011 concerning the postsurgical adhesion barrier, Seprafilm (chemically modified hyaluronic acid …See details»
Premarket Approval (PMA) - Food and Drug Administration
Establishment of clean hold times for new equipment used in the manufacturing process of Seprafilm Adhesion Barrier. - - Links on this page: Page Last Updated: 02/10/2025. Note: If …See details»
Preparation and Application Techniques - Baxter
SEPRAFILM (1-2 cm) Allow exposed SEPRAFILM to adhere to desired tissue Withdraw holder 1 2 3 Cut to any shape or size Curved or rolled Molded to desired contour 1 2 3 Open protective …See details»